Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $426.11 | 12 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $208.64 | 6 | $0 (2024) |
| AIMMUNE THERAPEUTICS, INC. | $124.99 | 1 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $38.08 | 2 | $0 (2024) |
| Novo Nordisk Inc | $22.04 | 1 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $17.05 | 1 | $0 (2024) |
| Exact Sciences Corporation | $15.31 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $403.15 | 11 | AstraZeneca Pharmaceuticals LP ($185.68) |
| 2023 | $22.96 | 1 | AstraZeneca Pharmaceuticals LP ($22.96) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/10/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 08/07/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Gastroenterology | ||||||
| 06/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $121.94 | General |
| Category: Respiratory | ||||||
| 06/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Respiratory | ||||||
| 05/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Respiratory | ||||||
| 04/23/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: Diabetes | ||||||
| 04/22/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Neuropsychiatry | ||||||
| 03/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Respiratory | ||||||
| 02/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Respiratory | ||||||
| 02/14/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Oncology | ||||||
| 01/17/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Neuropsychiatry | ||||||
| 12/18/2023 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 41 | 41 | $4,787 | $2,092 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 30 | $4,050 | $1,759 | 43.4% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 11 | 11 | $737.00 | $333.52 | 45.3% |
About David Cherry
David Cherry is a Emergency healthcare provider based in Bourbonnais, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2023. The National Provider Identifier (NPI) number assigned to this provider is 1427737659.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Cherry has received a total of $426.11 in payments from pharmaceutical and medical device companies, with $403.15 received in 2024. These payments were reported across 12 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($426.11).
As a Medicare-enrolled provider, Cherry has provided services to 41 Medicare beneficiaries, totaling 41 services with total Medicare billing of $2,092. Data is available for 1 year (2023–2023), covering 2 distinct procedure/service records.
Practice Information
- Specialty Emergency
- Other Specialties Family
- Location Bourbonnais, IL
- Active Since 07/14/2023
- Last Updated 02/10/2025
- Taxonomy Code 163WE0003X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1427737659
Products in Payments
- AIRSUPRA (Drug) $208.64
- ZENPEP (Drug) $124.99
- INGREZZA (Drug) $38.08
- Ozempic (Drug) $22.04
- XIFAXAN (Drug) $17.05
- Cologuard Collection Kit (Device) $15.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.